Nika Pharmaceuticals, Inc. (NIKA)

Market Cap	791.42M
Revenue (ttm)	n/a
Net Income	-51.76K
EPS	-0.00
Shares Out	1.05B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	159
Average Volume	7,432
Open	0.7555
Previous Close	0.3880
Day's Range	0.7555 - 0.7555
52-Week Range	0.2500 - 0.9574
Beta	-1.61
RSI	60.77
Earnings Date	Mar 27, 2026

About Nika Pharmaceuticals

Nika Pharmaceuticals, Inc., a pharmaceutical company, develops drugs for the treatment of HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, diabetes, and various other diseases. It offers dietary supplements and antiviral drugs, as well as thymus nuclear glycoprotein for the treatment of HIV. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2000
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: NIKA